Short Stature, Idiopathic: Clinical Trials

2 trials for Short Stature, Idiopathic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 41Completed 1

Follow Short Stature, Idiopathic: new trials by email Literature Review of Short Stature, Idiopathic trials Research Report on Short Stature, Idiopathic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.
Somatropin - Short Stature, Idiopathic, Infant, Small for Gestational Age
Phase 4CompletedLG Life Sciences1162016-08-112019-01-03
Pappalysin 2 (PAPP-A2) Enzyme Replacement
Fresh Frozen Plasma - Short Stature, Idiopathic
Phase 1CompletedChildren's Hospital Medical Center, Cincinnati12015-04-012015-05-28

Narrower conditions

Dwarfism (2)  ·  Dwarfism, Pituitary (1)  ·  Kidney Failure, Chronic (1)  ·  Turner Syndrome (1)

Broader conditions

Bone Diseases (2)  ·  Bone Diseases, Developmental (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Endocrine System Diseases (2)  ·  Genetic Diseases, Inborn (2)  ·  Musculoskeletal Diseases (2)  ·  Bone Diseases, Endocrine (1)  ·  Brain Diseases (1)  ·  Cardiovascular Abnormalities (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Chromosome Disorders (1)  ·  Chronic Disease (1)  ·  Congenital Abnormalities (1)  ·  Disease Attributes (1)

Interventions

Human Growth Hormone (1)

Sponsors

Children's Hospital Medical Center, Cincinnati (1)  ·  LG Life Sciences (1)

Countries

South Korea (1)  ·  United States (1)

Top investigators

Andrew Dauber, MD (1)

Results publications

PMID 31908426